Seqens recently inaugurated a new HPAPI unit for the production of highly active ingredients at its Villeneuve-La-Garenne site, in the presence of Emmanuel Macron, president of the French Republic, and Bruno Lemaire, minister of economy, finance and recovery.    This investment of $35 million in one of the three leading technologies in pharmaceutical synthesis, demonstrates the Seqens group’s ability to design, develop and industrialize complex molecules while maintaining a high level of...